The Board of Directors of the Company has inter-alia approved and taken on record unaudited Financial Results, as reviewed by the Audit Committee, for the quarter ended September 30., 2025. ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Raaj Medisafe India Ltd met on November 12, 2025 and approved the unaudited financial results for the quarter ended September 30, 2025, along with the cash flow statement and statement of assets and liabilities. The Board also approved related party transactions undertaken during the half year ended September 30, 2025. Additionally, the company has decided to avail a Term Loan of Rs. 12 crore from Bank of Baroda, Indore, and has authorized its Managing Director to execute the required documents. Routine items such as the Share Capital Audit Report, investor complaint status, shareholding pattern, and compliance certificates were also noted.
The fresh Rs. 12 crore term loan will increase the company's debt levels, which investors should track for any impact on interest costs and leverage ratios. Approval of related party transactions is a routine regulatory requirement but worth monitoring for fairness and transparency.